Delivery Order SPE2DB22D3501-SPE2DB25FXG27
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,075.01 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This competitively awarded, firm fixed price contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Durolane 60 mg/3 ml syringes at a ceiling value of $1,275.20. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's location...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,292.69 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on August 21, 2025. This competitively awarded, non-set-aside contract carries a ceiling value of $3,187.90 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,591.45 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $5.4K. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,347.52 by the Defense Logistics Agency on August 1, 2025, for Durolane 60 mg/3 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance is scheduled for completion by August 4, 2025, with work to be performed at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a $10,520.07 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This is a firm fixed price contract with an ultimate completion date of July 28, 2025, representing a non-set-aside procurement awarded competitively on July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXG27Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,736.84 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's comprehensive IDC vehicle enables it to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, and related medical commodities. This specific delivery order for Durolane, a hyaluronic acid-based injectable product, supports the medical supply needs of the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 9/10/25 |